EPAM Systems EPAM Stock Intrinsic Value Insight 148 20260427 Regeneron Pharmaceuticals REGN Bullish Investment Case Strengthens Post FDA Hearing Gene Therapy Approval Amid Temporary Share Pullback K2 Capital KTWOU Sector Leadership KTWOU Latest Quarter Earnings K2 Capital reports no operational financials ahead of deSPAC Phillips 66 PSX Western Gateway Pipeline Partnership Expands Refined Products Footprint in HighDemand US Southwest Markets